Labcorp Holdings Inc.
LH Healthcare Diagnostics & Research
Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.
Follow LH
Labcorp Holdings Inc. 10-K filed Feb 24, 2026
What changed
Item 7, Management’s Discussion and Analysis, against the 10-K filed Feb 25, 2025: 9 added · 13 removed · 43 modified; 4 with only figures updated
65 more changes in this Item, word by word, in Powerpack.
Powerpack